Infections Due to Drug-Resistant Pneumococci, Enterococci, and Mycobacterium tuberculosis

Pediatric Annals

Volumn 25, Issue 9, 1996, Pages 502-510

  English, B Keith ^a,b   Chesney, P Joan ^a,b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b LE BONHEUR CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CEFOTAXIME; CEPHALOSPORIN DERIVATIVE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; DRUG EFFECT; ENTEROCOCCUS; HUMAN; MYCOBACTERIUM TUBERCULOSIS; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; TUBERCULOSIS;

ANTI-BACTERIAL AGENTS; CEFOTAXIME; CEPHALOSPORINS; DRUG RESISTANCE, MICROBIAL; ENTEROCOCCUS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MYCOBACTERIUM TUBERCULOSIS; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE; TUBERCULOSIS, MULTIDRUG-RESISTANT; VANCOMYCIN;

EID: 0030225842     PISSN: 00904481     EISSN: None     Source Type: Journal    
DOI: 10.3928/0090-4481-19960901-08     Document Type: Article

References (51)

1. Klein JO Otitis media. Clin Infect Dis 1994;19:323-383
2. Klugman KP Pneumococcal resistance to antibiotics Clin Microbiol Rev. 1990;3:171-196.
3. Paris MM, Ramilo O, McCracken GH Jr Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae Antimicrob Agents Chemother 1995;39:2171-2175.
4. Sloas MM, Barrett FF, Chesney PJ, et al Cephalosporin treatment failure in penicillin and cephalosporin resistant Streptococcus pneumoniae meningitis. Pediatr Infect Dis J. 1992;11:662-666
5. Kleiman MB, Weinberg GA, Reynolds JK, Allen SD, Meningitis with beta lactam resistant Streptococcus pneumoniae: the need for early repeat lumbar puncture Pediatr Infect Dis J. 1993;12 782-784
6. Tan TQ, Schutze GE, Mason EO, Kaplan SL Antibiotic therapy and acute outcome of meningitis due to Streptococcus pneumoniae considered intermediately susceptible to broad-spectrum cephalosporins. Antimicrob Agents Chemother 1994;38 918-923
7. Viladrich PF, Cabellos C, Pallares R, et al High doses of cefotaxime in treatment of adult meningitis due to Streptococcus pneumoniae with decreased susceptibilities to broad spectrum cephalosporins Antimicrob Agents Chemother 1996;40:218-220
8. Hofmann J, Cetron MS, Farley MM, et al The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N Engl J Med 1995;333:481-486.
9. Block SL, Harrison CJ, Hedrick JA. Penicillin-resistant Streptococcus pneumoniae in acute otitis media: risk factors, susceptibility patterns and antimicrobial management Pediatr Infect Dis J 1995;14:751-759
10. Tan TQ, Mason EO Jr, Kaplan SL Penicillin-resistant systemic pneumococcal infections in children: a retrospective case-control study. Pediatrics 1993;92:761-767.
11. Friedland IR. Comparison of the response to antimicrobial therapy of penicillin-resistant and penicillin-susceptible pneumococcal disease Pediatr Infect Dis J 1995;14:885-890
12. Bradley JS, Kaplan SL, Klugman KP, Leggiadro RJ Consensus management of infections in children caused by Streptococcus pneumoniae with decreased susceptibility to penicillin. Pediatr Infect Dis J 1995;14 1037-1041
13. Viladrich PF, Gudiol F, Linares J Evaluation of vancomycin for therapy in adult pneumococcal meningitis Antimicrob Agents Chemother 1991;35:2467-2472.
14. Friedland IR, Klugman KP Failure of chloramphenicol therapy in penicillin resistant pneumococcal meningitis Lancet 1992;1:405-408.
15. Tan TQ, Mason EO, Kaplan SL. Systemic infections due to a Streptococcus pneumoniae relatively resistant to penicillin in a children's hospital: clinical management and outcome. Pediatrics. 1992;90:928-933.
16. Pallares R, Linares J, Vadillo M, et al Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain N Engl J Med 1995;333:474-480.
17. Spratt BG Resistance to antibiotics mediated by target alterations Science. 1994;264 353-393
18. Macias EA, Mason EO Jr, Ocera HY, LaRocco MT. Comparison of E test with standard broth microdilution for determining antibiotic susceptibilities of penicillin-resistant strains of Streptococcus pneumoniae. J Clin Microbiol. 1994;32:430-432
19. National Committee for Clinical Laboratory Standards Performance Standards For Antimicrobial Susceptibility Testing Sixth Informational Supplement M100-S6. Villanova, Pa: National Committee for Clinical Laboratory Standards; 1995.
20. Chesney PJ, Wilimas JA, Presbury G, et al. Penicillin- and cephalosporin-resistant strains of Streptococcus pneumoniae causing sepsis and meningitis in children with sickle cell disease J Pediatr. 1995;127:526-532
21. McCracken GH Jr. Emergence of resistant Streptococcus pneumoniae: a problem in pediatrics. Pediatr Infect Dis J. 1995;14:424-428.
22. Paradise JL Managing otitis media a time for change Pediatrics 1995;96 712-714
23. Klein DL. Pneumococcal conjugate vaccines. Review and update. Microbial Drug Resistance. 1995;1:49-58.
24. Centers for Disease Control and Prevention Defining the public health impact of drug-resistant Streptococcus pneumoniae. report of a working group MMWR Morb Mortal Wkly Rep. 1996,45(suppl):RR-1
25. Moellering RC Jr Enterococcus species, Streprococcus bovis, and Leuconostoc species. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases 4th ed. New York, NY: Churchill Livingstone; 1995:1826-1835.
26. Rice LB, Shlaes DM Vancomycin resistance in the enterococcus Pediatr Clin North Am. 1995;42:601-618
27. Shay DK, Goldman DA, Jarvis WR. Reducing the spread of antimicrobial-resistant microorganisms: control of vancomycin-resistant enterococci Pediatr Clin North Am 1995;42:703-716.
28. Murray BE. The life and times of the enterococcus Clin Microbiol Rev. 1990;3:46-65
29. Moellering RC Jr. Emergence of enterococcus as a significant pathogen Clin Infect Dis. 1992;14 1173-1176
30. Centers for Disease Control and Prevention. Nosocomial enterococci resistant to vancomycin. MMWR Morb Mortal Wkly Rep 1993;42:597-599
31. Centers for Disease Control and Prevention Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC) MMWR Morb Mortal Wkly Rep. 1995;44(RR-12):1-13
32. Jones RN, Sader HS, Erwin ME, et al. Emerging multiply resistant enterococci among clinical isolates, I prevalence data from 97 medical center surveillance study in the United States. Enterococcus study group Diagn Microbiol Infect Dis 1995;21:85-93
33. Arthur M, Courvalin P. Genetics and mechanisms of glycopeptide resistance in enterococci Antimicrob Agents Chemother 1993;37:1563-1571
34. Facklam RR, Sahm DR. Enterococcus In Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds Manual of Clinical Microbiology 6th ed Washington, DC. American Society for Microbiology, 1995:308-314
35. National Committee for Clinical Laboratory Standards Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically 3rd ed. Villanova, Pa: National Committee for Clinical Laboratory Standards, 1993 NCCLS publication M7-A3.
36. National Committee for Clinical Laboratory Standards Minimum Inhibitory Concentration (MIC) Interpretative Standards (μg/mL) for Organisms Other Than Haemophilus spp, Neisseria gonorrhoeae, and Streptococcus pneumoniae Fifth Informational Supplement Villanova, Pa: National Committee for Clinical Laboratory Standards, 1994 NCCLS Document M100-S5
37. Ad Hoc Committee of the Scientific Assembly on Microbiology, Tuberculosis, and Pulmonary Infections (Joint Statement of the American Thoracic Society and the Centers for Disease Control) Treatment of tuberculosis and tuberculosis infection in adults and children Clin Infect Dis 1995;20:219-227
38. Starke J, Jacobs R, Jereb J. Resurgence of tuberculosis in children. J Pediatr. 1992;120:839-855
39. Swanson D, Starke J Drug-resistant tuberculosis in pediatrics Pediatr Clin North Am 1995;42:553-581.
40. Centers for Disease Control Management of persons exposed to multidrug-resistant tuberculosis MMWR 1992;41(RR-11):61-71.
41. Centers for Disease Control Initial therapy for tuberculosis in the era of multidrug resistance: recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR. 1993,42(RR-7):1-8
42. Goble M, Iseman M, Madsen L, Waite D, Ackerson L, Horsburgh C Jr Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin N Engl J Med 1993;328:527-532
43. Jacobs RF. Recommendations for infection control in outpatient care for the prevention of tuberculosis Pediatr Infect Dis J 1994;13 939-940
44. Jacobs RF Multiple-drug-resistant tuberculosis. Clin Infect Dis 1994;19:1-8
45. Telenti A, Imboden P, Marchesi F, et al Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 1993;341 647-650.
46. Kapur V, Li L-L, Iordansecu S, et al. Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase (beta subunit) in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas J Clin Microbiol 1994; 32:1095-1098
47. Edlin BR, Tokars JI, Grieco MH, et al. An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med. 1992;326:1514-1521
48. Fischl MA, Uttamchandani RB, Daikos GL, et al. An outbreak of tuberculosis caused by multiple-drug-resistant tubercle bacilli among patients with HIV infection Ann Intern Med 1992;117:177-183
49. Salomon H, Perlman D, Friedmann P, Buchstein S, Kreiswirth B, Mildvan D. Predictors and outcome of multidrug-resistant tuberculosis Clin Infect Dis 1995;21:1245-1252
50. Turett G, Telzak E, Torian L, et al Improved outcomes for patients with multidrug-resistant tuberculosis Clin Infect Dis. 1995;21:1238-1244
51. Weis S, Slocurn P, Blais F, et al. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis N Engl J Med. 1994;330:1179-1184.